195 related articles for article (PubMed ID: 27075437)
21. The current evidence on statin use and prostate cancer prevention: are we there yet?
Alfaqih MA; Allott EH; Hamilton RJ; Freeman MR; Freedland SJ
Nat Rev Urol; 2017 Feb; 14(2):107-119. PubMed ID: 27779230
[TBL] [Abstract][Full Text] [Related]
22. The association between statins exposure and peripheral neuropathy risk: A meta-analysis.
Wang M; Li M; Xie Y
J Clin Pharm Ther; 2021 Aug; 46(4):1046-1054. PubMed ID: 33629752
[TBL] [Abstract][Full Text] [Related]
23. Diabetes mellitus and prostate cancer risk of different grade or stage: a systematic review and meta-analysis.
Xu H; Jiang HW; Ding GX; Zhang H; Zhang LM; Mao SH; Ding Q
Diabetes Res Clin Pract; 2013 Mar; 99(3):241-9. PubMed ID: 23298664
[TBL] [Abstract][Full Text] [Related]
24. Is use of vitamin K antagonists associated with the risk of prostate cancer?: A meta-analysis.
Luo JD; Luo J; Lai C; Chen J; Meng HZ
Medicine (Baltimore); 2018 Dec; 97(49):e13489. PubMed ID: 30544443
[TBL] [Abstract][Full Text] [Related]
25. Mediterranean dietary pattern and the risk of prostate cancer: A meta-analysis.
Cheng S; Zheng Q; Ding G; Li G
Medicine (Baltimore); 2019 Jul; 98(27):e16341. PubMed ID: 31277188
[TBL] [Abstract][Full Text] [Related]
26. Active commuting and the risk of obesity, hypertension and diabetes: a systematic review and meta-analysis of observational studies.
Wu J; Li Q; Feng Y; Bhuyan SS; Tarimo CS; Zeng X; Wu C; Chen N; Miao Y
BMJ Glob Health; 2021 Jun; 6(6):. PubMed ID: 34172487
[TBL] [Abstract][Full Text] [Related]
27. Do statins lower testosterone and does it matter?
Sniderman AD; Thanassoulis G
BMC Med; 2013 Feb; 11():58. PubMed ID: 23448188
[TBL] [Abstract][Full Text] [Related]
28. Local Failure in High-grade Prostate Cancer: An Elusive but Important Outcome and Target for Clinical Trials.
Alibhai SMH; Warde P
Eur Urol; 2020 Feb; 77(2):209-210. PubMed ID: 31787428
[No Abstract] [Full Text] [Related]
29. Association between statins and clinical outcomes among men with prostate cancer: a systematic review and meta-analysis.
Raval AD; Thakker D; Negi H; Vyas A; Salkini MW
Prostate Cancer Prostatic Dis; 2016 Jun; 19(2):222. PubMed ID: 26857024
[No Abstract] [Full Text] [Related]
30. Prostate cancer: time to trial statins?
Farley SJ
Nat Rev Urol; 2010 Jul; 7(7):359. PubMed ID: 20665931
[No Abstract] [Full Text] [Related]
31. Statins Use and Risk of Breast Cancer Recurrence and Death: A Systematic Review and Meta-Analysis of Observational Studies.
Mansourian M; Haghjooy-Javanmard S; Eshraghi A; Vaseghi G; Hayatshahi A; Thomas J
J Pharm Pharm Sci; 2016; 19(1):72-81. PubMed ID: 27096694
[TBL] [Abstract][Full Text] [Related]
32. Radioligand Therapy With 177Lu-PSMA-617 as A Novel Therapeutic Option in Patients With Metastatic Castration Resistant Prostate Cancer.
Rahbar K; Bode A; Weckesser M; Avramovic N; Claesener M; Stegger L; Bögemann M
Clin Nucl Med; 2016 Jul; 41(7):522-8. PubMed ID: 27088387
[TBL] [Abstract][Full Text] [Related]
33. Clinical efficacy and safety of evolocumab for low-density lipoprotein cholesterol reduction.
Henry CA; Lyon RA; Ling H
Vasc Health Risk Manag; 2016; 12():163-9. PubMed ID: 27143910
[TBL] [Abstract][Full Text] [Related]
34. Prognostic Value of Neutrophil-to-Lymphocyte Ratio in Localized and Advanced Prostate Cancer: A Systematic Review and Meta-Analysis.
Tang L; Li X; Wang B; Luo G; Gu L; Chen L; Liu K; Gao Y; Zhang X
PLoS One; 2016; 11(4):e0153981. PubMed ID: 27096158
[TBL] [Abstract][Full Text] [Related]
35. Hypercholesterolemia Is Associated with a Shorter Time to Castration-Resistant Prostate Cancer in Patients Who Have Undergone Androgen Deprivation Therapy.
Jeon JC; Park J; Park S; Moon KH; Cheon SH; Park S
World J Mens Health; 2016 Apr; 34(1):28-33. PubMed ID: 27169126
[TBL] [Abstract][Full Text] [Related]
36. [Enzalutamide and Abiraterone in the Treatment of Metastatic Castration-resistant Prostate Cancer after Chemotherapy].
Richter I; Dvořák J; Hejzlarová V; Chalupa J; Sochor M; Stankuš I; Barsová L; Holikova M; Forster J; Bartoš J
Klin Onkol; 2016; 29(2):127-32. PubMed ID: 27081803
[TBL] [Abstract][Full Text] [Related]
37. Cardiovascular Effect of Incretin-Based Therapy in Patients with Type 2 Diabetes Mellitus: Systematic Review and Meta-Analysis.
Kim JY; Yang S; Lee JI; Chang MJ
PLoS One; 2016; 11(4):e0153502. PubMed ID: 27078018
[TBL] [Abstract][Full Text] [Related]
38. Association between genetically proxied PCSK9 inhibition and prostate cancer risk: A Mendelian randomisation study.
Fang S; Yarmolinsky J; Gill D; Bull CJ; Perks CM; ; Davey Smith G; Gaunt TR; Richardson TG
PLoS Med; 2023 Jan; 20(1):e1003988. PubMed ID: 36595504
[TBL] [Abstract][Full Text] [Related]
39. Combining evidence from Mendelian randomization and colocalization: Review and comparison of approaches.
Zuber V; Grinberg NF; Gill D; Manipur I; Slob EAW; Patel A; Wallace C; Burgess S
Am J Hum Genet; 2022 May; 109(5):767-782. PubMed ID: 35452592
[TBL] [Abstract][Full Text] [Related]
40. Associations of genetically proxied inhibition of HMG-CoA reductase, NPC1L1, and PCSK9 with breast cancer and prostate cancer.
Sun L; Ding H; Jia Y; Shi M; Guo D; Yang P; Wang Y; Liu F; Zhang Y; Zhu Z
Breast Cancer Res; 2022 Feb; 24(1):12. PubMed ID: 35151363
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
